JPWO2021039932A1 - - Google Patents

Info

Publication number
JPWO2021039932A1
JPWO2021039932A1 JP2021543018A JP2021543018A JPWO2021039932A1 JP WO2021039932 A1 JPWO2021039932 A1 JP WO2021039932A1 JP 2021543018 A JP2021543018 A JP 2021543018A JP 2021543018 A JP2021543018 A JP 2021543018A JP WO2021039932 A1 JPWO2021039932 A1 JP WO2021039932A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021543018A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021039932A1 publication Critical patent/JPWO2021039932A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2021543018A 2019-08-28 2020-08-27 Pending JPWO2021039932A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019155910 2019-08-28
PCT/JP2020/032470 WO2021039932A1 (ja) 2019-08-28 2020-08-27 再発寛解型多発性硬化症、二次進行型多発性硬化症、非典型多発性硬化症及び視神経脊髄炎類縁疾患の診断方法、並びに診断用バイオマーカー

Publications (1)

Publication Number Publication Date
JPWO2021039932A1 true JPWO2021039932A1 (zh) 2021-03-04

Family

ID=74685079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021543018A Pending JPWO2021039932A1 (zh) 2019-08-28 2020-08-27

Country Status (2)

Country Link
JP (1) JPWO2021039932A1 (zh)
WO (1) WO2021039932A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220333159A1 (en) * 2021-04-07 2022-10-20 The United States Government As Represented By The Department Of Veterans Affairs Compositions And Methods Useful In Detecting And Diagnosing Multiple Sclerosis
WO2024090455A1 (ja) * 2022-10-25 2024-05-02 国立研究開発法人国立精神・神経医療研究センター 多発性硬化症の診断方法及び診断用バイオマーカー

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2017034031A1 (ja) * 2015-08-27 2018-06-14 国立研究開発法人国立精神・神経医療研究センター 自己免疫疾患の診断方法、自己免疫疾患の診断用バイオマーカー、及び自己免疫疾患の予防又は治療剤
CN109715177A (zh) * 2016-03-14 2019-05-03 赫罗微生物群公司 调节消化道微生物组以治疗精神病或中枢神经系统疾病

Also Published As

Publication number Publication date
WO2021039932A1 (ja) 2021-03-04

Similar Documents

Publication Publication Date Title
BR112019017762A2 (zh)
BR112021013854A2 (zh)
BR112021018450A2 (zh)
BR112021020990A2 (zh)
BR112019016141A2 (zh)
AU2020104490A4 (zh)
BR112019016138A2 (zh)
BR112019016142A2 (zh)
BR112021018168A2 (zh)
BR112021008711A2 (zh)
BR112021018452A2 (zh)
BR112021018102A2 (zh)
BR112021017083A2 (zh)
JPWO2021039932A1 (zh)
BR112021012348A2 (zh)
BR112021018250A2 (zh)
BR112021018093A2 (zh)
BR112021013944A2 (zh)
BR112021013128A2 (zh)
BR112021018484A2 (zh)
BR112021015080A2 (zh)
BR112021016205A2 (zh)
BR112021016996A2 (zh)
BR112021017010A2 (zh)
AT524962A5 (zh)

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A801

Effective date: 20220105

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20220105